Journal
CHEMICAL SCIENCE
Volume 12, Issue 9, Pages 3130-3145Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0sc06557a
Keywords
-
Categories
Funding
- Key Research and Development Program of Shandong Province [2018YFJH0502]
- National Natural Science Foundation of China [21927811, 21874086, 21775094]
- National Key R&D Program of China [2019YFA0210100]
- Youth Innovation Science and Technology Program of Higher Education Institution of Shandong Province [2019KJC022]
Ask authors/readers for more resources
Cancer immunotherapy utilizes the body's immune system to fight cancer, but direct injection of immunomodulators may lead to excessive immune response. Therefore, the development of intelligent stimuli-responsive nano immunomodulators is crucial for amplifying anti-tumor responses safely and effectively.
Cancer immunotherapy is a revolutionary treatment method in oncology, which uses a human's own immune system against cancer. Many immunomodulators that trigger an immune response have been developed and applied in cancer immunotherapy. However, there is the risk of causing an excessive immune response upon directly injecting common immunomodulators into the human body to trigger an immune response. Therefore, the development of intelligent stimuli-responsive immunomodulators to elicit controlled immune responses in cancer immunotherapy is of great significance. Nanotechnology offers the possibility of designing smart nanomedicine to amplify the antitumor response in a safe and effective manner. Progress relating to intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy is highlighted as a new creative direction in the field. Considering the clinical demand for cancer immunotherapy, we put forward some suggestions for constructing new intelligent stimuli-responsive nano immunomodulators, which will advance the development of cancer immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available